Schweiger Dermatology Group Enhances Access with Same-Week Appointments

Schweiger Dermatology Group, a prominent name in dermatological care in the United States, has announced significant advancements in patient accessibility and skin cancer treatment as of December 5, 2025. With over 2.5 million patient visits throughout the year, the practice has made strides in offering same-week appointments, thus enhancing its commitment to providing timely care.

Founded in 2010 by board-certified dermatologist Dr. Eric Schweiger, the organization operates with a mission to deliver the Ultimate Patient Experience. This commitment is evident in the practice’s ability to minimize wait times and offer immediate evaluations for various dermatological needs, including medical, cosmetic, and surgical treatments.

Focus on Early Skin Cancer Detection

Skin cancer remains the most common cancer in the United States, and early detection plays a crucial role in improving patient outcomes. Dr. Schweiger emphasized the importance of timely care, stating, “Our priority has always been to get patients seen quickly, treated promptly, and cared for with the highest clinical excellence.” To this end, Schweiger Dermatology provides comprehensive full-body skin examinations aimed at identifying suspicious lesions early, often catching cancers at their most treatable stages.

Advanced Skin Cancer Treatment Options

The organization has solidified its position as a leader in skin cancer treatment, performing over 36,000 Mohs surgeries in 2025 alone. This makes Schweiger Dermatology one of the largest providers of Mohs care in the country. Their offerings include:

– Mohs micrographic surgery conducted by fellowship-trained surgeons
– Surgical excisions and minimally invasive removal techniques
– Ongoing screening and long-term surveillance programs

Dr. Glen Crawford, Chief Medical Officer, remarked on the significance of quick access to dermatology, stating, “Dermatology delivers its greatest impact when patients can access it quickly, and that is where Schweiger Dermatology truly stands apart.” He noted that the practice’s expansion in clinical capabilities not only alleviates patient discomfort and anxiety but also facilitates earlier diagnoses of skin cancers and other serious conditions.

The practice prides itself on a patient-centered model that emphasizes quality, trust, and convenience. With a team of over 70 board-certified dermatologists recognized as Castle Connolly Top Doctors, the organization reflects clinical excellence across all specialties. Patient satisfaction remains high, with more than 90% of patients rating their experience as four or five stars.

In addition to its clinical achievements, Schweiger Dermatology Group has been recognized in 2025 as one of the largest private companies in the New York area by Crain’s. It also marks its ninth consecutive year on the Inc. 5000 list of the fastest-growing companies in America, underscoring its rapid expansion and commitment to outstanding care.

Schweiger Dermatology Group continues to redefine dermatological care through its innovative and accessible approach. Patients can expect expert skin care that is easy to access, often with appointments available within days. For more information, visit schweigerderm.com.